Taipei, March 29 (CNA) An enterovirus vaccine developed in Taiwan has proved highly successful in the animal testing stage and is set to proceed to human clinical trials, a researcher at the National Health Research Institutes (NHRI) said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
September export orders hit record high
10/20/2021 08:18 PM - Culture
Taiwanese education kit for migrant workers wins Japan design award
10/20/2021 07:52 PM - Science & Tech
Acer announces plan for cybersecurity school
10/20/2021 07:35 PM - Science & Tech
MIH Consortium unveils open electronic vehicle software platform
10/20/2021 07:11 PM - Society
CHEM officials receive jail terms for armored vehicle procurement fraud
10/20/2021 05:57 PM
